Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Scorpion’s sting may hold clue for managing heart failure

It was only a pilot study, and only in mice, and it requires harvesting venom from scorpions—no easy task. But a first report on a venom-based peptide points to a new compound for treating patients with acute heart failure.

Thumbnail

Review gives CRT with defibrillators, pacemakers high marks

Cardiac resynchronization with defibrillators (CRT-D) or pacemakers (CRT-P) fared well in an assessment of their benefits to Medicare beneficiaries. The document will remain available for review and comment through Dec. 15.

Results in mid-risk patients give next-gen TAVR valve a boost

Transcatheter aortic valve replacement (TAVR) likely stepped closer to use in intermediate-risk patients after a multicenter study found patients who underwent transfemoral TAVR with a next-generation valve had a 30-day mortality rate of 2.1 percent.

Thumbnail

Aggressively managing risk factors improves outcomes after ablations

Aggressive management of risk factors may be the key to improving patient outcomes following ablation for atrial fibrillation. Findings published Dec. 2 in the Journal of the American College of Cardiology suggest that in patients with a high body mass index and more than one cardiovascular risk factor, improved long-term outcomes are possible when several risk factors were addressed.

ZOLL snaps up Philips’ InnerCool assets

ZOLL Medical is buying the assets from Philips’ InnerCool temperature management business, which includes several products cleared for use in the U.S.

Biodegradable DES passes in best-of-class analysis

A biodegradable drug-eluting stent (DES) proved to be noninferior to durable-polymer DES and both showed benefits over bare-metal stents (BMS) in the BASKET-PROVE II clinical trial. The results published online Nov. 19 in Circulation also raise questions about triggers for late complications.

Mortality findings raise more concerns over digoxin's use

Atrial fibrillation patients taking digoxin may have a 71 percent higher risk of dying, according to a study published online Nov. 20 in Circulation: Arrythmia and Electrophysiology.

Key antiplatelet presentation yields more questions than answers

Paul A. Gurbel, MD, director of the Sinai Center for Thrombosis Research in Baltimore, provides perspective on the Dual Antiplatelet Therapy study results presented at the American Heart Association conference in Chicago and future directions.  

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.